ICU Medical, Inc. (NASDAQ:ICUI) is reporting third quarter financial results on Thursday 5th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, ICUI is expected to report 3Q20 income of $ 1.31 per share from revenue of $ 284.70 million.
For the full year, analysts anticipate top line of $ 1184.10 million, while looking forward to income of $ 6.40 per share bottom line.
The Company Outlook
Full Year 2020 bottomline are predicted in a range of $ 5.95 ~ $ 6.65 per share
Click Here For More Historical Outlooks Of ICU Medical, Inc.
Previous Quarter Performance
ICU Medical, Inc. unfold income for the second quarter of $ 1.65 per share, from the revenue of $ 303.38 million. The quarterly earnings contracted 17.09 percent compared with the same quarter last year. According to street consensus, ICUI was expected to report 2Q20 income of $ 1.24 per share from revenue of $ 276.70 million. The bottom line results beat street analysts by $ 0.41 or 33.06 percent, at the same time, top line results outshined analysts by $ 26.68 million or 9.64 percent.
Stock Performance
Shares of ICU Medical, Inc. traded up $ 0.41 or 0.22 percent on Wednesday, reaching $ 187.06 with volume of 136.90 thousand shares. ICU Medical, Inc. has traded high as $ 191.65 and has cracked $ 185.00 on the downward trend
The closing price of $ 187.06, representing a 18.13 % increase from the 52 week low of $ 158.01 and a 21.08 % decrease over the 52 week high of $ 236.51.
The company has a market capital of $ 3.92 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
ICU Medical, Inc. will be hosting a conference call at 4:30 PM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.icumed.com
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patients vein.
